MANILA, Philippines — The camp of Department of Public Works and Highways (DPWH) District Engineer Henry Alcantara denied accusations linking him to alleged ghost flood control projects in Bulacan, insisting he had no hand in the supposed scheme.
In a statement issued over the weekend, the Flaminiano Arroyo & Dueñas law firm, which represents Alcantara, said its client “maintains his innocence: he did not author these alleged ghost projects. Any wrongdoing was done behind his back, without his knowledge, acquiescence, or approval.”

DPWH engineer denies role in Bulacan flood control ‘ghost projects’
The statement directly counters claims that Alcantara was the “kingpin” of the controversial projects, which authorities are now investigating for possible irregularities.
“Engr. Alcantara will contest every accusation that he had supposedly participated in and/or benefitted from any unlawful scheme,” the law firm said, adding that he would exhaust all legal remedies, including challenging his summary dismissal from service.
The camp also vowed Alcantara’s cooperation with the ongoing investigation. “He will continue to assist the authorities in the investigation of these flood control ghost projects. We are confident that in due time, the truth will surface and Engr. Alcantara will be cleared of the baseless accusations levied against him,” the statement read., This news data comes from:http://ml-aesu-pae-ylu.gangzhifhm.com
- Comelec to resume BARMM polls ballot printing Thursday
- Thousands protest in Indonesia as military deployed in capital
- China races to build world’s largest solar farm
- Macron's decision to recognize Palestinian state angers Israel and the US
- Napolcom confirms Lt. Gen. Nartatez as acting PNP chief
- Maduro hits ‘illegal’ US troops deployment
- Sarah Discaya grilled by Senate over alleged DPWH links
- Some areas in Metro Manila, Bulacan, Quezon to have power interruptions due to maintenance work
- Duterte Youth brings Comelec cancelation battle to Supreme Court
- Trump plans a hefty tax on imported drugs, risking higher prices and shortages